Additional file1. Fig S1. Generation of the Akaluc-expressing hiPSC line. Fig S2. Flow cytometric analysis. Fig S3. qRT-PCR analysis. Fig S4. Immunocytochemistry. Fig S5. Comparison of Luc2- and Akaluc-expressing hiPSCs. Fig S6. Echocardiography. Fig S7. BLI. Fig S8. Assessment of the graft size and composition of hiPSC-CMs at 1 and 12 weeks post-transplantation. Fig S9. Cell proliferation in grafts at 4 and 8 weeks post-transplantation. Fig S10. Apoptosis in grafts at 4 and 8 weeks post-transplantation. Fig S11. Microvessels in grafts and in vitro assays for assessing angiogenesis by hiPSC-CMs. Fig S12. Angiogenesis profiler array and qRT-PCR. Fig S13. Expression of CRYAB in hiPSC-CMs. Fig S14. AAV-mediated CRYAB overexpression. Table S1. ...
Table S4. Results of the tube formation assays for angiogenesis. One-way ANOVA providing the number ...
Identification of MSCs by Flow Cytometry. (A) Representative histogram of FACS results showing the M...
Table S6. Results of the tube formation assays for angiogenesis. One-way ANOVA providing the number ...
Figure S3. Phenotypic characterization of hiPSC-CMs. hiPSC-CMs were characterized using specific cel...
Figure S2. Effect of I/R injury on hiPSCs-hCMs without maturation step. Viability of hiPSC-CMs after...
Abstract Background Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) can be us...
Table S3. Presenting human angiogenesis and tissue recovery-related proteins analyzed in PCMO cell c...
Table S1. Quantitative RT-PCR primer sequences. Table S2 Antibodies used for immunofluorescence and ...
Immunocytochemical analysis of pluripotency status of hESCs cultured over Matrigel. Figure S2. Immun...
Figure S1. Showing characterization of human iPSCs and differentiated cardiomyocytes. (A) qRT-PCR de...
Figure S1. Phenotypic characterization of hCPCs. hCPCs were characterized using specific cell marker...
Flow cytometric analysis of the pluripotent markers (TRA-1-60, SSEA4), hematopoietic markers (CD34, ...
Differentiation of hiPSCs to endothelial cells through an MESP1+ mesoderm progenitor stage. (a) FACS...
Showing enrichment of human MLC-2v-positive early ventricular cardiomyocytes from hiPSCs. a, b Addin...
Figure S6. Nestin+ BMSCs stimulates endogenous CECs recruiting via CXCL12/CXCR4 signaling pathway. (...
Table S4. Results of the tube formation assays for angiogenesis. One-way ANOVA providing the number ...
Identification of MSCs by Flow Cytometry. (A) Representative histogram of FACS results showing the M...
Table S6. Results of the tube formation assays for angiogenesis. One-way ANOVA providing the number ...
Figure S3. Phenotypic characterization of hiPSC-CMs. hiPSC-CMs were characterized using specific cel...
Figure S2. Effect of I/R injury on hiPSCs-hCMs without maturation step. Viability of hiPSC-CMs after...
Abstract Background Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) can be us...
Table S3. Presenting human angiogenesis and tissue recovery-related proteins analyzed in PCMO cell c...
Table S1. Quantitative RT-PCR primer sequences. Table S2 Antibodies used for immunofluorescence and ...
Immunocytochemical analysis of pluripotency status of hESCs cultured over Matrigel. Figure S2. Immun...
Figure S1. Showing characterization of human iPSCs and differentiated cardiomyocytes. (A) qRT-PCR de...
Figure S1. Phenotypic characterization of hCPCs. hCPCs were characterized using specific cell marker...
Flow cytometric analysis of the pluripotent markers (TRA-1-60, SSEA4), hematopoietic markers (CD34, ...
Differentiation of hiPSCs to endothelial cells through an MESP1+ mesoderm progenitor stage. (a) FACS...
Showing enrichment of human MLC-2v-positive early ventricular cardiomyocytes from hiPSCs. a, b Addin...
Figure S6. Nestin+ BMSCs stimulates endogenous CECs recruiting via CXCL12/CXCR4 signaling pathway. (...
Table S4. Results of the tube formation assays for angiogenesis. One-way ANOVA providing the number ...
Identification of MSCs by Flow Cytometry. (A) Representative histogram of FACS results showing the M...
Table S6. Results of the tube formation assays for angiogenesis. One-way ANOVA providing the number ...